LINC00173 facilitates tumor progression by stimulating RAB1B‐mediated PA2G4 and SDF4 secretion in nasopharyngeal carcinoma. Issue 3 (23rd January 2023)
- Record Type:
- Journal Article
- Title:
- LINC00173 facilitates tumor progression by stimulating RAB1B‐mediated PA2G4 and SDF4 secretion in nasopharyngeal carcinoma. Issue 3 (23rd January 2023)
- Main Title:
- LINC00173 facilitates tumor progression by stimulating RAB1B‐mediated PA2G4 and SDF4 secretion in nasopharyngeal carcinoma
- Authors:
- He, Shi‐Wei
Liang, Ye‐Lin
Zhang, Yuan
Liu, Xu
Gong, Sha
Ye, Ming‐Liang
Huang, Sheng‐Yan
Tan, Xi‐Rong
Zhou, Shi‐Qing
Zhao, Yin
Liu, Na
Li, Ying‐Qing - Abstract:
- Abstract : An increasing number of studies have found that long non‐coding RNA (lncRNA) play important roles in driving the progression of nasopharyngeal carcinoma (NPC). Our microarray screening revealed that expression of the lncRNA long intergenic non‐protein coding RNA 173 ( LINC00173 ) was upregulated in NPC. However, its role and mechanism in NPC have not yet been elucidated. In this study, we demonstrate that high LINC00173 expression indicated a poor prognosis in NPC patients. Knockdown of LINC00173 significantly inhibited NPC cell proliferation, migration and invasion in vitro . Mechanistically, LINC00173 interacted and colocalized with Ras‐related protein Rab‐1B (RAB1B) in the cytoplasm, but the modulation of LINC00173 expression did not affect the expression of RAB1B at either the mRNA or protein levels. Instead, relying on the stimulation of RAB1B, LINC00173 could facilitate the extracellular secretion of proliferation‐associated 2G4 (PA2G4) and stromal cell‐derived factor 4 (SDF4; also known as 45‐kDa calcium‐binding protein) proteins, and knockdown of these proteins could reverse the NPC aggressive phenotype induced by LINC00173 overexpression. Moreover, in vivo LINC00173 ‐knockdown models exhibited a marked slowdown in tumor growth and a significant reduction in lymph node and lung metastases. In summary, LINC00173 serves as a crucial driver for NPC progression, and the LINC00173 –RAB1B–PA2G4/SDF4 axis might provide a potential therapeutic target for NPCAbstract : An increasing number of studies have found that long non‐coding RNA (lncRNA) play important roles in driving the progression of nasopharyngeal carcinoma (NPC). Our microarray screening revealed that expression of the lncRNA long intergenic non‐protein coding RNA 173 ( LINC00173 ) was upregulated in NPC. However, its role and mechanism in NPC have not yet been elucidated. In this study, we demonstrate that high LINC00173 expression indicated a poor prognosis in NPC patients. Knockdown of LINC00173 significantly inhibited NPC cell proliferation, migration and invasion in vitro . Mechanistically, LINC00173 interacted and colocalized with Ras‐related protein Rab‐1B (RAB1B) in the cytoplasm, but the modulation of LINC00173 expression did not affect the expression of RAB1B at either the mRNA or protein levels. Instead, relying on the stimulation of RAB1B, LINC00173 could facilitate the extracellular secretion of proliferation‐associated 2G4 (PA2G4) and stromal cell‐derived factor 4 (SDF4; also known as 45‐kDa calcium‐binding protein) proteins, and knockdown of these proteins could reverse the NPC aggressive phenotype induced by LINC00173 overexpression. Moreover, in vivo LINC00173 ‐knockdown models exhibited a marked slowdown in tumor growth and a significant reduction in lymph node and lung metastases. In summary, LINC00173 serves as a crucial driver for NPC progression, and the LINC00173 –RAB1B–PA2G4/SDF4 axis might provide a potential therapeutic target for NPC patients. Abstract : Our study shows that LINC00173 is upregulated in nasopharyngeal carcinoma (NPC) and is associated with poor prognosis of patients. LINC00173 directly binds and interacts with RAB1B, subsequently facilitates PA2G4 and SDF4 secretion through exocytosis pathway, finally, promotes NPC cell proliferation, migration, invasion and metastasis. The LINC00173 –RAB1B–PA2G4/SDF4 axis might provide a potential therapeutic target for NPC patients. … (more)
- Is Part Of:
- Molecular oncology. Volume 17:Issue 3(2023)
- Journal:
- Molecular oncology
- Issue:
- Volume 17:Issue 3(2023)
- Issue Display:
- Volume 17, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 17
- Issue:
- 3
- Issue Sort Value:
- 2023-0017-0003-0000
- Page Start:
- 518
- Page End:
- 533
- Publication Date:
- 2023-01-23
- Subjects:
- LINC00173 -- nasopharyngeal carcinoma -- PA2G4 -- RAB1B -- SDF4
Cancer -- Molecular aspects -- Periodicals
616.994005 - Journal URLs:
- http://www.journals.elsevier.com/molecular-oncology/ ↗
http://febs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)1878-0261/issues/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/1878-0261.13375 ↗
- Languages:
- English
- ISSNs:
- 1574-7891
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.817993
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26112.xml